Couverture de The Dales Report | Trade to Black

The Dales Report | Trade to Black

The Dales Report | Trade to Black

De : Dales Media Group
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

We are a business news platform that provides the latest and best insight into the stories that make headlines worldwide. From cannabis to psychedelics, crypto and more, we give institutional and retail investors an inside edge in the competitive world of investing. And we profile companies that are making waves in their ever-growing industries. We are The Dales Report. The information provided in this podcast is for educational purposes only and should not be considered as financial or investment advice. Listeners are encouraged to conduct their own research and coDales Media Group Economie Finances privées
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Why Branding Is Becoming Cannabis’s Biggest Advantage | TDR Cannabis in 5
      Jan 14 2026
      Why is branding becoming one of the most important separating factors in the cannabis industry as we move deeper into 2026?This episode of TDR Cannabis in Five takes a closer look at how the cannabis market is shifting from survival mode into a more mature, consumer-driven phase — and why brand identity is starting to matter as much as cultivation, pricing, or retail footprint.For years, cannabis companies were focused on staying afloat amid price compression, limited access to capital, and regulatory uncertainty. But as the industry inches closer to potential uplisting, banking reform, and broader institutional participation, the competitive landscape is changing. Companies are no longer being judged solely on scale or cost efficiency. Increasingly, they’re being evaluated on whether they can build durable brands that consumers recognize, trust, and return to.This episode uses cannabis stock MariMed (OTCQX: MRMD) as a case study, focusing on its edible brand Betty’s Eddies. Rather than chasing rapid expansion, MariMed invested early in brand development — from product formulation and packaging to positioning that aligns more closely with wellness and consumer packaged goods than novelty cannabis products.The discussion also looks at how Betty’s Eddies has performed in highly competitive markets like Massachusetts and Illinois, including its ability to regain momentum after a multi-year absence from shelves. That kind of portability — where a brand can exit a market and successfully re-enter later — highlights the long-term value of brand equity in cannabis.As the industry continues to mature, this episode frames branding not as marketing hype, but as infrastructure — something that can support pricing power, repeat purchases, and long-term resilience as competition intensifies.#CannabisBranding #CannabisIndustry #MariMed #MRMD #BettysEddies #CannabisCPG #CannabisEdibles #CannabisInvesting #CannabisMarkets #CannabisStocksWant to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
      Afficher plus Afficher moins
      7 min
    • Which States Are Most Likely to Legalize Cannabis in 2026? | TDR Cannabis in 5
      Jan 13 2026
      Which states are actually positioned to legalize marijuana in 2026 — and which ones just keep showing up in headlines without real momentum?That’s the question this episode of TDR Cannabis in Five, presented by Flowhub, takes on using new reporting and data highlighted by Marijuana Moment. With federal cannabis rescheduling hanging in the balance, state-level reform is back in focus — and in some cases, it may matter more than ever.As of early 2026, nearly half of U.S. states already allow adult-use cannabis, and most permit medical access. But reform hasn’t stalled. Instead, it’s shifted into a more targeted phase, where a handful of states show real, measurable movement — through ballot initiatives, legislative action, or political alignment — while others remain stuck.This episode breaks down the states most likely to see progress next year, including Florida, where a 2026 adult-use ballot initiative is moving through legal review, and Pennsylvania, where lawmakers continue debating legalization as a revenue and regulatory issue. It also looks at states like New Hampshire and Hawaii, where legislative momentum has quietly been building, and Virginia, where adult possession is legal but retail sales still haven’t launched.Medical cannabis is part of the story too. States like Idaho and Kansas — long resistant to reform — are seeing renewed efforts to establish medical programs, while North Carolina and South Carolina continue to study or debate next steps.Rather than predicting outcomes, this episode focuses on where the policy pressure points actually are — and what those state-level moves say about how cannabis reform is unfolding in a post-rescheduling environment.#CannabisLegalization #CannabisPolicy #MarijuanaMoment #CannabisReform #StateLegalization #Cannabis2026 #CannabisNews #CannabisIndustry #MedicalCannabis #AdultUseCannabisWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
      Afficher plus Afficher moins
      9 min
    • GOP Pushes Back on Rescheduling Fears | TDR Cannabis in 5
      Jan 13 2026
      So… is cannabis rescheduling actually happening, or are we stuck watching another slow-motion government process?That’s the question a lot of people are asking right now — especially after the DEA confirmed the rescheduling appeal process is still technically pending, even after President Trump’s executive order. On the surface, that sounds like a delay. But once you slow things down and look at how this process actually works, the story gets a lot clearer.In this episode of TDR Cannabis in Five presented by Flowhub, Shadd Dales breaks down where things really stand with federal cannabis rescheduling — and why “pending” doesn’t mean “dead.” A Republican lawmaker closely involved in cannabis policy, Rep. Dave Joyce of Ohio, says concerns about the DOJ dragging its feet are overblown. According to Joyce, Trump was very clear in directing federal agencies to move cannabis out of Schedule I and into Schedule III.Here’s the key point: executive orders don’t flip a switch overnight. They start a process — one that involves scientific review, administrative steps, and legal safeguards. That’s exactly where we are now.This episode walks through what Schedule III would actually change — and what it wouldn’t. Easier research access? Yes. Potential tax relief for operators? Possibly. Instant legalization or federal free-for-all? Not even close.We also talk about why lawsuits are expected, why they face an uphill battle, and why alignment between the White House, HHS, and the DEA matters more than daily headlines.Bottom line: this isn’t a story about whether rescheduling happens. It’s about timing, execution, and making sure it sticks.And that’s where things get interesting.#CannabisRescheduling #ScheduleIII #CannabisPolicy #FederalCannabis #TDRCannabisInFive #CannabisReform #CannabisIndustry #DEA #DOJ #FlowhubWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
      Afficher plus Afficher moins
      7 min
    Aucun commentaire pour le moment